A5085028300- Vasculitis and related conditions
- Rheumatoid Arthritis Research and Therapies
- Otitis Media and Relapsing Polychondritis
- Systemic Lupus Erythematosus Research
- Musculoskeletal Disorders and Rehabilitation
- Osteoarthritis Treatment and Mechanisms
- Innovations in Medical Education
- Autoimmune and Inflammatory Disorders Research
- Sarcoidosis and Beryllium Toxicity Research
- Renal Diseases and Glomerulopathies
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Urticaria and Related Conditions
- Kawasaki Disease and Coronary Complications
- Heparin-Induced Thrombocytopenia and Thrombosis
- Diversity and Career in Medicine
- Clinical Reasoning and Diagnostic Skills
- Immune Cell Function and Interaction
- Chronic Lymphocytic Leukemia Research
- Coronary Artery Anomalies
- Systemic Sclerosis and Related Diseases
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Cardiac Structural Anomalies and Repair
- Orthopedic Infections and Treatments
- Inflammasome and immune disorders
- SARS-CoV-2 and COVID-19 Research
Northwestern University
2019-2024
American College of Rheumatology
2020-2024
Northwestern Memorial Hospital
2022-2023
Jaipur National University
2022
Center for Rheumatology
2016-2021
AID Atlanta
2020
Northwestern Medicine
2020
Women's Hospital
2020
University of Chicago
2018-2019
Allegheny Health Network
2013
To develop international consensus-based recommendations for early referral of individuals with suspected polymyalgia rheumatica (PMR).
Objective To provide evidence‐based recommendations and expert guidance for the management of Kawasaki disease (KD), focusing on clinical scenarios more commonly addressed by rheumatologists. Methods Sixteen questions regarding diagnostic testing, treatment, KD were developed in Patient/Population, Intervention, Comparison, Outcomes (PICO) question format. Systematic literature reviews conducted each PICO question. We used Grading Recommendations, Assessment, Development Evaluation method to...
Objectives To evaluate the efficacy and safety of avacopan in subgroup patients with antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis receiving background induction therapy rituximab phase 3 ADVOCATE trial. Methods Key outcomes were remission at week 26 sustained 52. Additional included Glucocorticoid Toxicity Index, estimated glomerular filtration rate, urinary albumin to creatinine ratio, health-related quality life safety. Results Of 330 who received study medication,...
Objective. Patients with myositis-associated interstitial lung disease (MA-ILD) are often refractory to conventional treatment, and predicting their response therapy is challenging. Recent case reports small series suggest that tacrolimus may be useful in cases. Methods. A retrospective cohort study of patients MA-ILD comparing clinical characteristics between those who responded or failed treatment. In treatment received adjunctive tacrolimus, was measured by the improvement myositis, ILD,...
Objective To provide evidence‐based recommendations and expert guidance for the management of Kawasaki disease (KD), focusing on clinical scenarios more commonly addressed by rheumatologists. Methods Sixteen questions regarding diagnostic testing, treatment, KD were developed in Patient/Population, Intervention, Comparison, Outcomes (PICO) question format. Systematic literature reviews conducted each PICO question. We used Grading Recommendations, Assessment, Development Evaluation method to...
In patients with unilateral end-stage hip osteoarthritis (OA), the contralateral knee is known to be at greater risk for OA compared ipsilateral (i.e., same-side) knee. The have increased dynamic joint loads present study was undertaken examine who had but did not symptoms of OA, in order detect early asymmetries loading.Data on 62 were evaluated. Patients underwent gait analyses as well dual x-ray absorptiometry determination bone mineral density (BMD) both knees. Differences between knees...